Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

IJMS, Free Full-Text

Bioprospecting for Anti-COVID-19 Interventions From African Medicinal Plants: A Review - Abidemi J. Akindele, Abimbola Sowemimo, Foluso O. Agunbiade, Margaret O. Sofidiya, Olufunsho Awodele, Omobolanle Ade-Ademilua, Ifeoma Orabueze, Ismail O. Ishola

Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis

A Reappraisal of the Antiviral Properties of and Immune Regulation through Dietary Phytochemicals

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Frontiers Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents

Extracts from artemisia annua plant found to be active against SARS-CoV-2 virus under laboratory conditions

Frontiers Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents

Life, Free Full-Text

Molecules, Free Full-Text

Frontiers Natural Plant Products: A Less Focused Aspect for the COVID-19 Viral Outbreak

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants

IJMS, Free Full-Text

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2, Cell & Bioscience

Pathogens, Free Full-Text